Song, Rui Lin 宋瑞霖
Main board
| Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | China Resources Boya Bio-pharmaceutical Group Co., Ltd. | Ind DirIndependent Director | 2017-03 | |||||
| 2 | * | JACOBIO PHARMACEUTICALS GROUP CO., LTD. | INEDIndependent Non-Executive Director | 2020-12-21 | -83.36% | -34.82% | -34.97% | |
| 3 | * | Luye Pharma Group Ltd. | NEDNon-Executive Director | 2017-03-29 | -47.24% | -7.76% | -10.21% | |
| 4 | * | Mediwelcome Healthcare Management & Technology Inc. | INEDIndependent Non-Executive Director | 2020-12-21 | -86.81% | -38.91% | -37.27% | |
| 5 | * | Shanghai Henlius Biotech, Inc. | INEDIndependent Non-Executive Director | 2019-09-02 | -44.49% | -10.27% | -11.16% | |
| 6 | Shanxi Zhendong Pharmaceutical Co., Ltd. | Ind DirIndependent Director | 2015-06 | |||||
| 7 | Shenzhen Chipscreen Biosciences Co., Ltd. | Ind DirIndependent Director | 2018-06 | |||||
| 8 | * | Simcere Pharmaceutical Group Limited | INEDIndependent Non-Executive Director | 2019-11-19 | -21.38% | -5.39% | -6.95% | |
| 9 | Tibet Aim Pharm. Inc. | Ind DirIndependent Director | 2015-08 | |||||
| Average | -19.43% | -20.11% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy